Overview
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 27, 2025 | Lumea Enhances Digital Pathology Platform with AI-Powered Urine Cytology Solution Through AIxMed Partnership | Lumea and AIxMed team up to bring AI-driven urine cytology to Lumea's platform, targeting improved bladder cancer diagnostics. LEHI, UT, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Lumea, a leading provider of primary clinical digital... |
| Jun 6, 2023 | AIxMed Welcomes Barbara Crothers, D.O., as Chief Scientist and Appoints Two Scientific Advisors | AIxMed, an early-stage smart Cytology company at the intersection of artificial intelligence (AI) and medicine, announced the appointment of Cytopathology industry heavyweight Barbara Crothers, D.O., as Chief Scientist. In this new executiv... |
| Apr 27, 2023 | AIxMed Lands $2.75M | SANTA CLARA, CA, AIxMed announced that it has raised $2.75 million. >> Click here for more funding data on AIxMed >> To export AIxMed funding data to PDF and Excel, click here AIxMed, an early-stage smart cytology company... |
| Apr 27, 2023 | AIxMed Raises $2.75M in SAFE Funding | AlxMed, a Santa Clara, CA-based early-stage smart cytology company, raised $2.75M in SAFE funding. The backers were not disclosed. The company intends to use the funds to further develop its digital cytology platform. Fundraising proceeds w... |
| AIxMed | “Transforming Digital Cytology.” | |
| AIxMed | “Home” |
Reviews 0
FAQ about Beyond Human Insight
What has the press written about Beyond Human Insight?
Parsers VC has collected 7 articles mentioning Beyond Human Insight, among them “Lumea Enhances Digital Pathology Platform with AI-Powered Urine Cytology Solution Through AIxMed Partnership” (May 27, 2025) and “AIxMed Welcomes Barbara Crothers, D.O., as Chief Scientist and Appoints Two Scientific Advisors” (Jun 6, 2023).
Is Beyond Human Insight still active?
Yes, Beyond Human Insight is active; its latest activity on Parsers VC dates from Mar 20, 2026.